Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-295,246
Closed -$244K 189
2025
Q1
$244K Hold
295,246
0.01% 165
2024
Q4
$280K Hold
295,246
0.01% 168
2024
Q3
$295K Hold
295,246
0.01% 164
2024
Q2
$366K Buy
+295,246
New +$301K 0.02% 135

GenTrust's KRON Position: Q2 2025 in Review

GenTrust sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 295,246 shares — an estimated $244K sold.

GenTrust first reported a position in KRON in Q2 2024 and held it in 4 quarters. The position peaked at $366K in Q2 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • GenTrust reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • GenTrust sold 295,246 Kronos Bio shares in Q2 2025, an estimated $244K.
  • GenTrust first reported a position in Kronos Bio in Q2 2024 and held it in 4 quarters.
  • GenTrust's Kronos Bio position peaked at $366K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on GenTrust's 13F filing for Q2 2025, filed 31 Jul 2025.